June 11, 2019 - Minneapolis, MN - Leading pharmacogenomics company OneOme today announced the launch of OneOme Institute, its new educational venture. OneOme Institute was developed to help advance the use of PGx in clinical practice worldwide.
MINNEAPOLIS (October 10, 2017) – Today, OneOme announced it has been named a finalist for the 18th Annual Minnesota High Tech Association (MHTA) Tekne Awards in the Healthcare category. The Tekne Awards honor Minnesota companies and individuals who have shown superior technology innovation and leadership. OneOme’s RightMed® pharmacogenomic solution identifies how a patient's DNA and current medications may affect their response to medications.